SPL 1.08% 9.4¢ starpharma holdings limited

Not so good deal, page-29

  1. 47 Posts.
    lightbulb Created with Sketch. 9
    Aristarchus - Maybe, but it is not as easy as you might think. Will ITF be able to offer a better compensation package to new field reps than their current employer? Many experienced field reps also have "non-compete" clauses in their contracts. And do not overlook the huge scale of the US market. It takes a lot of reps to generate the sales volume we are hoping for.

    Also, allow me to repeat that the pharmacy distribution chains (CVS, Walgreens, etc) do not have much impact on the sale of prescription drugs in the US. The doctor writes a script for the patient, the patient takes the script to whatever pharmacy. The price may vary, but availability usually does not from store to store. What does have a critical impact is the decision of the insurance companies to provide coverage for a new drug.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $829 8.824K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 50000 1
View Market Depth
Last trade - 12.01pm 08/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.